192 related articles for article (PubMed ID: 22696596)
1. Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients.
Xiong D; Li G; Li K; Xu Q; Pan Z; Ding F; Vedell P; Liu P; Cui P; Hua X; Jiang H; Yin Y; Zhu Z; Li X; Zhang B; Ma D; Wang Y; You M
Carcinogenesis; 2012 Sep; 33(9):1797-805. PubMed ID: 22696596
[TBL] [Abstract][Full Text] [Related]
2. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
[TBL] [Abstract][Full Text] [Related]
3. Exome sequencing identifies frequent mutation of MLL2 in non-small cell lung carcinoma from Chinese patients.
Yin S; Yang J; Lin B; Deng W; Zhang Y; Yi X; Shi Y; Tao Y; Cai J; Wu CI; Zhao G; Hurst LD; Zhang J; Hu L; Kong X
Sci Rep; 2014 Aug; 4():6036. PubMed ID: 25112956
[TBL] [Abstract][Full Text] [Related]
4. Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing.
Liu P; Morrison C; Wang L; Xiong D; Vedell P; Cui P; Hua X; Ding F; Lu Y; James M; Ebben JD; Xu H; Adjei AA; Head K; Andrae JW; Tschannen MR; Jacob H; Pan J; Zhang Q; Van den Bergh F; Xiao H; Lo KC; Patel J; Richmond T; Watt MA; Albert T; Selzer R; Anderson M; Wang J; Wang Y; Starnes S; Yang P; You M
Carcinogenesis; 2012 Jul; 33(7):1270-6. PubMed ID: 22510280
[TBL] [Abstract][Full Text] [Related]
5. Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy.
Sun S; Du W; Sun Q; Zhao X; Qin B; Shi D; Wan C; Wu Z
Cancer Med; 2021 Oct; 10(20):7360-7372. PubMed ID: 34599863
[TBL] [Abstract][Full Text] [Related]
6. Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing.
Shajani-Yi Z; de Abreu FB; Peterson JD; Tsongalis GJ
Neoplasia; 2018 Mar; 20(3):256-262. PubMed ID: 29454261
[TBL] [Abstract][Full Text] [Related]
7. Targeted next-generation sequencing for cancer-associated gene mutation and copy number detection in 206 patients with non-small-cell lung cancer.
Zheng S; Wang X; Fu Y; Li B; Xu J; Wang H; Huang Z; Xu H; Qiu Y; Shi Y; Li K
Bioengineered; 2021 Dec; 12(1):791-802. PubMed ID: 33629637
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and prognostic value of KRAS co-mutation subtypes in Chinese advanced non-small cell lung cancer patients.
Cai D; Hu C; Li L; Deng S; Yang J; Han-Zhang H; Li M
Cancer Med; 2020 Jan; 9(1):84-93. PubMed ID: 31709742
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.
Shigematsu H; Lin L; Takahashi T; Nomura M; Suzuki M; Wistuba II; Fong KM; Lee H; Toyooka S; Shimizu N; Fujisawa T; Feng Z; Roth JA; Herz J; Minna JD; Gazdar AF
J Natl Cancer Inst; 2005 Mar; 97(5):339-46. PubMed ID: 15741570
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic alterations of the LKB1 gene and their associations with mutations in TP53 and EGFR pathway genes in Korean non-small cell lung cancers.
Lee SM; Choi JE; Na YK; Lee EJ; Lee WK; Choi YY; Yoon GS; Jeon HS; Kim DS; Park JY
Lung Cancer; 2013 Aug; 81(2):194-9. PubMed ID: 23664447
[TBL] [Abstract][Full Text] [Related]
11. K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways.
Scheffler M; Ihle MA; Hein R; Merkelbach-Bruse S; Scheel AH; Siemanowski J; Brägelmann J; Kron A; Abedpour N; Ueckeroth F; Schüller M; Koleczko S; Michels S; Fassunke J; Pasternack H; Heydt C; Serke M; Fischer R; Schulte W; Gerigk U; Nogova L; Ko YD; Abdulla DSY; Riedel R; Kambartel KO; Lorenz J; Sauerland I; Randerath W; Kaminsky B; Hagmeyer L; Grohé C; Eisert A; Frank R; Gogl L; Schaepers C; Holzem A; Hellmich M; Thomas RK; Peifer M; Sos ML; Büttner R; Wolf J
J Thorac Oncol; 2019 Apr; 14(4):606-616. PubMed ID: 30605727
[TBL] [Abstract][Full Text] [Related]
12. Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas.
Liang X; Li Q; Xu B; Hu S; Wang Q; Li Y; Zong Y; Zhang S; Li C
Int J Clin Oncol; 2019 Sep; 24(9):1061-1068. PubMed ID: 31065835
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients.
Koivunen JP; Kim J; Lee J; Rogers AM; Park JO; Zhao X; Naoki K; Okamoto I; Nakagawa K; Yeap BY; Meyerson M; Wong KK; Richards WG; Sugarbaker DJ; Johnson BE; Jänne PA
Br J Cancer; 2008 Jul; 99(2):245-52. PubMed ID: 18594528
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients.
Wang R; Zhang Y; Pan Y; Li Y; Hu H; Cai D; Li H; Ye T; Luo X; Zhang Y; Li B; Shen L; Sun Y; Chen H
Oncotarget; 2015 Oct; 6(33):34300-8. PubMed ID: 26486077
[TBL] [Abstract][Full Text] [Related]
15. Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer.
Jing C; Mao X; Wang Z; Sun K; Ma R; Wu J; Cao H
Mol Med Rep; 2018 Aug; 18(2):2191-2197. PubMed ID: 29956783
[TBL] [Abstract][Full Text] [Related]
16. Target-based genomic profiling of ctDNA from Chinese non-small cell lung cancer patients: a result of real-world data.
Chen H; Wang A; Wang J; He Z; Mao Y; Liu L
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1867-1876. PubMed ID: 32221744
[TBL] [Abstract][Full Text] [Related]
17. Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer.
Hu W; Liu Y; Chen J
Oncotarget; 2017 Apr; 8(15):25046-25054. PubMed ID: 28212572
[TBL] [Abstract][Full Text] [Related]
18. Hot spot mutations in Finnish non-small cell lung cancers.
Mäki-Nevala S; Sarhadi VK; Rönty M; Kettunen E; Husgafvel-Pursiainen K; Wolff H; Knuuttila A; Knuutila S
Lung Cancer; 2016 Sep; 99():102-10. PubMed ID: 27565922
[TBL] [Abstract][Full Text] [Related]
19. Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.
Zhang Q; Sun T; Kang P; Qian K; Deng B; Zhou J; Wang R; Jiang B; Li K; Liu F; Wu S; Tan Q
Cancer Chemother Pharmacol; 2016 Mar; 77(3):583-93. PubMed ID: 26842788
[TBL] [Abstract][Full Text] [Related]
20. Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer.
Kadara H; Sivakumar S; Jakubek Y; San Lucas FA; Lang W; McDowell T; Weber Z; Behrens C; Davies GE; Kalhor N; Moran C; El-Zein R; Mehran R; Swisher SG; Wang J; Zhang J; Fujimoto J; Fowler J; Heymach JV; Dubinett S; Spira AE; Ehli EA; Wistuba II; Scheet P
Am J Respir Crit Care Med; 2019 Sep; 200(6):742-750. PubMed ID: 30896962
[No Abstract] [Full Text] [Related]
[Next] [New Search]
